The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia
Internal Medicine Journal · 2023
DOI: 10.1111/imj.16049 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Internal Medicine Journal, 2023. Verfasst von Shirlene Sim und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Frailty, Multiple Myeloma. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Multiple myeloma (MM) is a disease of older people, yet factors relating to comorbidity and frailty may threaten treatment tolerability for many of this heterogenous group. There has been increasing interest in defining specific and clinically relevant frailty assessment tools within the MM population, with the goal of using these frailty scores, not just as a prognostic instrument, but also as a predictive tool to allow for a frailty‐adapted treatment approach. This paper reviews the various frailty assessment frameworks used in the evaluation of patients with MM, including the International Myeloma Working Group Frailty Index (IMWG‐FI), the Mayo Frailty Index and the simplified frailty scale. While the IMWG‐FI remains the most widely accepted tool, the simplified frailty scale is the most user‐friendly in busy day‐to‐day clinics based on its ease of use. This paper summarises the recommendations from the Myeloma Scientific Advisory Group (MSAG) of Myeloma Australia, on the use of frailty assessment tools in clinical practice and proposes a frailty‐stratified treatment algorithm to aid clinicians in tailoring therapy for this highly heterogeneous patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia.
- Department of Haematology, Alfred Hospital, Melbourne, Victoria, Australia.
- Department of Geriatric Medicine, Alfred Health, Melbourne, Victoria, Australia.
- Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
- Department of Medicine, University of Queensland, Queensland, Brisbane, Australia.
- Department of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Shirlene Sim, Simon Gibbs, Jeff Szer, Dipti Talaulikar, Andrew Zannettino
Zitieren
APA
Sim, S., Kalff, A., Tuch, G., Mollee, P., Ho, P. J., Harrison, S., Gibbs, S., Prince, H. M., Spencer, A., Joshua, D., Lee, C., Ling, S., Murphy, N., Szabo, F., Szer, J., Weber, N., Ward, C., Talaulikar, D., Zannettino, A., & Quach, H. (2023). The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia. Internal Medicine Journal. https://doi.org/10.1111/imj.16049
Vancouver
Sim S, Kalff A, Tuch G, Mollee P, Ho PJ, Harrison S, et al. The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia. Internal Medicine Journal. 2023. doi:10.1111/imj.16049
BibTeX
@article{Sim2023,
author = {Sim, Shirlene and Kalff, Anna and Tuch, Gina and Mollee, Peter and Ho, P Joy and Harrison, Simon and Gibbs, Simon and Prince, H Miles and Spencer, Andrew and Joshua, Douglas and Lee, Cindy and Ling, Silvia and Murphy, Nick and Szabo, Ferenc and Szer, Jeff and Weber, Nicholas and Ward, Christopher and Talaulikar, Dipti and Zannettino, Andrew and Quach, Hang},
title = {The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia},
journal = {Internal Medicine Journal},
year = {2023},
doi = {10.1111/imj.16049}
}
EUVIMED